Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02837536 · ClinicalTrials.gov registry record · NA
Horizontal vs. Vertical Positioning of the iCare Rebound Tonometer and Effects on Intraocular Pressure Readings
A NA study of Intraocular Pressure, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- NA
- Development phase
- 107
- Enrollment target
- 1
- Study location
NCT02837536: Completed NA study of Intraocular Pressure, sponsored by The University of Texas Health Science Center, Houston.
NCT02837536 is a NA study of Intraocular Pressure that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 107 participants, above the 76-participant average among 9 other Intraocular Pressure trials with a reported enrollment target (41% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02837536, a NA study of Intraocular Pressure, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- NA
- Development phase
- 107 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to evaluate the agreement between intraocular pressure (IOP) measurements taken by iCare, held in both vertical and horizontal positions. In addition, iCare measurements will be compared against pneumotonometry measurements to assess for accuracy.
Conditions Studied
Interventions
- OTHER Horizontal iCare
- OTHER Vertical iCare
Study Locations (1)
Texas
- Robert Cizik Eye Clinic - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 107 participants |
| Start Date | 2016-06-23 |
| Est. Completion | 2016-12-23 |
| Phase | NA |
What the finished NCT02837536 record still lists
NCT02837536 is an interventional study that assigns participants to a tested intervention. The registered 107 participants enrollment target is mid-sized for trials with a published cap, above the 76-participant average among 9 other Intraocular Pressure trials with a reported enrollment target (41% higher).
The record links to 1 condition, with Intraocular Pressure appearing as the primary indexed condition, and to 2 interventions - of which Horizontal iCare is the first listed.
NCT02837536 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT02837536 about?
NCT02837536 is a clinical study titled "Horizontal vs. Vertical Positioning of the iCare Rebound Tonometer and Effects on Intraocular Pressure Readings". The goal of this study is to evaluate the agreement between intraocular pressure (IOP) measurements taken by iCare, held in both vertical and horizontal positions. In addition, iCare measurements will be compared against pneumotonometry measurements to assess for accuracy.
What is the current status of trial NCT02837536?
This trial is currently completed. It is a NA study. The enrollment target is 107 participants. The study started on 2016-06-23. Estimated completion is 2016-12-23.
What conditions does trial NCT02837536 study?
This clinical trial studies the following conditions: Intraocular Pressure.
What interventions are being tested in trial NCT02837536?
The interventions under investigation include: Horizontal iCare (OTHER), Vertical iCare (OTHER).
Who is sponsoring clinical trial NCT02837536?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02837536 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Intraocular Pressure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02837536's enrollment target sits among peer trials
107 5th of 9 higher than 5 of 9 other Intraocular Pressure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Intraocular Pressure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effect of Raised End-Tidal pCo2 on Choroidal Volume
RECRUITING · NA
-
IOP Elevation Study
RECRUITING · NA
-
Cutaneous Prostaglandin Application: Nail Growth, Nail Brittleness, and Eye Pressure
COMPLETED · NA
-
Effect of Position and Anesthetic Choice in Intraocular Pressure in Robotic GYN (Gynecologic) Oncology Patients
RECRUITING · Phase 4
-
24-hour Wear Performance and Safety Study of Smartlens miLens Contact Lens for IOP Monitoring
RECRUITING
-
Anterior Segment Optical Coherence Tomography Microstent Positioning
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05491668 · 107 participants
Physiological Assessment of Severe Coronary Stenosis for Informing Planned PCI
- NCT06041594 · 107 participants · NA
Treating Pulmonary Embolism With Laguna Thrombectomy System (TRUST)
- NCT06081426 · 107 participants · NA
Examining Neurobiological Mechanisms Underlying the Therapeutic Effect of the Ketogenic Diet in Bipolar Disorder (BD)
- NCT06527599 · 107 participants · NA
Screening in Trauma for Opioid Misuse Prevention - an Adaptive Intervention
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI